Skip to Content
Merck
CN

HADK2MAG-61K

MILLIPLEX® Human Adipokine Panel

Configurable Human Adipokine 8-Plex Panel 2

Synonym(s):

adipocyte inflammation marker listing, adipokine assay snapshot, adipokine biomarker profile, adipose tissue cytokine panel, human adipokine assay overview, human adipokine panel summary, human cytokine product info, human metabolic research tool, inflammation and metabolism biomarker kit, multiplex adipokine product sheet

Sign In to View Organizational & Contract Pricing.

About This Item

UNSPSC Code:
12161503
NACRES:
NA.47
eCl@ss:
32161000


Product Name

MILLIPLEX® Human Adipokine Panel, Configurable Human Adipokine 8-Plex Panel 2

Quality Level

species reactivity

human

packaging

pkg of 1 ea

manufacturer/tradename

Milliplex®

assay range

inter-assay cv: <15%
intra-assay cv: <10%
(IL-1β), inter-assay cv: <15%
intra-assay cv: <10%
(IL-6), inter-assay cv: <15%
intra-assay cv: <10%
(IL-8), inter-assay cv: <15%
intra-assay cv: <10%
(Insulin), inter-assay cv: <15%
intra-assay cv: <10%
(Leptin), inter-assay cv: <15%
intra-assay cv: <10%
(MCP-1), inter-assay cv: <15%
intra-assay cv: <10%
(NGF), inter-assay cv: <20%
intra-assay cv: <10%
(TNFα), accuracy: 87%
(IL-8), accuracy: 91%
(TNFα), accuracy: 94%
(Insulin), standard curve range: 0.64-10,000 pg/mL
(IL-8), standard curve range: 0.64-10,000 pg/mL
(NGF), standard curve range: 0.64-10,000 pg/mL
(TNF-α), standard curve range: 0.96-15,000 pg/mL
(IL-6), standard curve range: 1.3-20,000 pg/mL
(IL-1β), standard curve range: 1.3-20,000 pg/mL
(MCP-1), standard curve range: 38-600,000 pg/mL
(Leptin), standard curve range: 9.6-150,000 pg/mL
(HGF), standard curve range: 9.6-150,000 pg/mL
(Insulin)

technique(s)

multiplexing: suitable

input

serum plasma

detection method

fluorometric (Luminex® xMAP® technology)

shipped in

wet ice

storage temp.

2-8°C

General description

Adipokines are signaling proteins secreted by adipose tissue that influence inflammation, metabolism, and energy balance. This set of biomarkers—IL-1β, IL-6, IL-8/CXCL8, Insulin, Leptin, MCP-1/CCL2, NGF, and TNFα—captures the interplay between metabolic regulation and immune response. These analytes are associated with insulin sensitivity, appetite control, inflammatory signaling, and neuroimmune interactions, making them highly relevant for research in obesity, type 2 diabetes, cardiovascular disease, and chronic inflammation.

Application

MILLIPLEX® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze up to 8 analytes in human serum or plasma samples.

Analytes included: IL-1β, IL-6, IL-8/CXCL8, Insulin, Leptin, MCP-1/CCL2, NGF, TNFα

Assay Characteristics: Refer to assay protocol for details on cross-reactivity, sensitivity, precision, and accuracy.

Features and Benefits

Features:
  • Targets key adipokines and cytokines involved in metabolic and inflammatory pathways
  • Includes 8 analytes relevant to insulin signaling, immune response, and adipose tissue function
  • Multiplex format enables simultaneous detection from minimal sample volume
  • Compatible with human serum and plasma samples
  • Designed for research in obesity, insulin resistance, inflammation, and metabolic syndrome
Benefits:
  • Provides a comprehensive profile of inflammatory and metabolic biomarkers
  • Supports investigation of adipose tissue dysfunction and systemic inflammation
  • Facilitates evaluation of therapeutic interventions in metabolic and endocrine disorders
  • Enables high-throughput analysis with reduced sample and reagent use
  • Delivers reproducible, sensitive results for translational and clinical research

Legal Information

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Disclaimer

For research use only. Not for use in diagnostic procedures.

Label License/Sticker for Assay Product:

By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.


Still not finding the right product?

Explore all of our products under MILLIPLEX® Human Adipokine Panel


pictograms

Skull and crossbonesEnvironment

signalword

Danger

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1

Regulatory Information

新产品

This item has



Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library


Related Content

Multiplex immunoassays, such as MILLIPLEX® multiplex metabolic assays, are critical in metabolic syndrome research because they provide a full picture of the different conditions related to it, like diabetes and obesity, as well as save time and sample volume.

View All Related Content

Waist-to-height ratio, waist circumference and BMI as indicators of percentage fat mass and cardiometabolic risk factors in children aged 3-7 years.
Sijtsma, A; Bocca, G; L'abee, C; Liem, ET; Sauer, PJ; Corpeleijn, E
Clinical Nutrition (Edinburgh, Scotland) null
Insulin resistance is associated with Fibroblast Growth Factor-23 in stage 3-5 chronic kidney disease patients.
Garland, JS; Holden, RM; Ross, R; Adams, MA; Nolan, RL; Hopman, WM; Morton, AR
Journal of Diabetes and Its Complications null
Yuek Ling Chai et al.
Scientific reports, 11(1), 4010-4010 (2021-02-19)
Cerebrovascular disease (CeVD) and neurodegenerative dementia such as Alzheimer's disease (AD) are frequently associated comorbidities in the elderly, sharing common risk factors and pathophysiological mechanisms including neuroinflammation. Osteopontin (OPN) is an inflammatory marker found upregulated in vascular diseases as well